Cornercap Investment Counsel Inc Alx Oncology Holdings Inc Transaction History

Cornercap Investment Counsel Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$5.84 - $17.56 $864 - $2,598	-148 Reduced 1.42%	10,292 $62,000
Q1 2024 May 10, 2024	BUY	$10.95 - $16.79 $114,317 - $175,287	10,440 New	10,440 $116,000
Q3 2023 Nov 13, 2023	BUY	$4.19 - $7.35 $9,586 - $16,816	2,288 Added 6.98%	35,071 $168,000
Q2 2023 Aug 11, 2023	BUY	$4.37 - $9.56 $143,261 - $313,405	32,783 New	32,783 $246,000

101

39.7M

134K

17.4K

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $74.6M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Cornercap Investment Counsel Inc with notifications on news.